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INTRODUCTION
Interleukin-1 (IL-1 ) is one of the multifunctional cyto-
kines produced predominantly by activated monocytes and
macrophages (1). It exerts not only pleiotropic effects in host
reactions such as immune defence, inflammation and homeo-
stasis (2), but also regulates a variety of cell functions of many
cell types in both positive and negative manners. For instance,
in human thymocytes, B cells and fibroblasts, IL-1 acts as
a growth stimulator for the cell proliferation (3-5), while
growth of some other cells, such as human endothelial cells,
breast carcinoma cells, mouse myeloid leukemia cells and
human melanoma cells, is inhibited by IL-1 (6-9). Previous
studies reported that IL-1 induced growth inhibition in
human melanoma cells through down-regulation of ornithine
decarboxylase (ODC) (10, 11), up-regulation of IL-6 (12)
and cell cycle arrest (13). Research carried out by Itoh and
his coworkers also indicated that this antiproliferative effect
was mediated by p38 mitogen-activated protein kinase (p38
MAPK) (14). Since human melanoma A375-S2 cell exhibits
the highest sensitivity to IL-1 in cell death and was used
to determine the activity of IL-1 (15), we selected this cell
line to conduct the present study.
In general, cells die through two distinct ways: apoptosis
or necrosis. In this study, IL-1 -induced death of A375-S2
cells represented some characteristics of apoptosis by morpho-
logic observation under phase contrast microscopy. To verify
that IL-1 promotes cell death through apoptotic pathways
in A375-S2 cells, caspases, Bcl-2 family proteins and apop-
tosis inclucing factor (AIF), which have been proved to play
important roles in the process of cellular apoptosis, were detect-
ed by the caspase activity assay and Western blot analysis.
Cysteine proteases of the caspase family play a role in the apop-
totic signaling and the execution of apoptosis by cleaving
critical cellular proteins solely after aspartate residues. The
main function of initiator caspases such as caspase-8 and -9
is to activate downstream executor caspases such as caspase-3,
which ultimate in apoptosis by cleavage of death substrates
(16, 17). It was considered that caspase-1 is also an important
upstream caspase (16), which not only mediate apoptosis,
but also cleave the precursor of IL-1 into bioactive cytokine
(18). Bcl-2 family proteins are vital for regulation of apop-
tosis by controlling the mitochondrial membrane potential
to release cytochrome c and activating caspase-9, -3 (19, 20).
The balance between proapoptotic proteins and antiapoptotic
proteins determine the fate of cells (21, 22). In mitochondria-
dependent cell death, translocation of AIF from mitochon-
dria and its activation are induced by the activation of cas-
pase-9 pathway (23). In addition, the production of endoge-
nous cytokine has also aroused our interest.
In this study we demonstrated that activation of caspases,
AIF and induction of endogenous IL-1 contributed to IL-
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IL-1 Acts in Synergy with Endogenous IL-1 in A375-S2 Human
Melanoma Cell Apoptosis Through Mitochondrial Pathway 
Interleukin-1 (IL-1 ) is a pivotal proinflammatory cytokine. To investigate the mech-
anism of IL-1 -induced cell death in human malignant melanoma A375-S2 cells,
MTT assay, photomicroscopical observation, DNA agarose gel electrophoresis,
radioimmunoassay and Western blot analysis were carried out. IL-1 did not only
induce nuclear condensation and DNA fragmentation, but also increased degra-
dation of two substrates of caspase-3, poly ADP-ribose polymerase (PARP) and
inhibitor of caspase-activated DNase (ICAD). Simultaneously, release of precursor
of IL-1 (pro-IL-1 ) and endogenous IL-1 production were involved in the apop-
totic process. IL-1 enhanced the ratio of Bax/Bcl-2 and Bax/Bcl-xL expression and
up-regulated apoptosis inducing factor (AIF) expression, which required the activation
of downstream caspases. These results suggest that IL-1 induces endogenous
IL-1 production, enhances cleavage of caspase downstream substrates and pro-
motes mitochondria mediated apoptosis in A375-S2 cells.
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1 -induced A375-S2 cell apoptosis, and up-regulation of
Bax, and down-regulation of Bcl-2, Bcl-xL amplified the acti-
vation of caspase cascade in this process.
MATERIALS AND METHODS
Materials
Human recombinant IL-1 , IL-1 , TNF- and IL-6 pro-
teins expressed by transfected Escherichia coli were purified
by chromatography on DEAE-Sepharose Fast Flow (Amer-
sham Pharmacia Biotech, Uppsala, Sweden) and concentrat-
ed by dialysis membrane. The purified recombinant proteins
with theoretical molecular mass were analyzed by 15% poly-
acrylamide gel electrophoresis with sodium dodecyl sulfate
(SDS-PAGE). 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-
tetra zolium (MTT), RNase and proteinase K were obtained
from Sigma Chemical (St. Louis, MO, U.S.A.). Rabbit poly-
clonal antiserum against pro-IL-1 was prepared in our lab-
oratory. Rabbit polyclonal antibodies against PARP, ICAD,
Bax, AIF and mouse polyclonal antibody against Bcl-2 were
purchased from Santa Cruz Biotechnology (Santa Cruz, CA,
U.S.A.). Mouse polyclonal antibody against Bcl-xL was from
Oncogene Research Products (Boston, MA, U.S.A.). 
Cell lines and cell culture 
Human malignant melanoma cell, A375-S2, was obtained
from the American Type Culture Collection (#CRL-1872,
Manassas, VA, U.S.A.). The cells were cultured in RPMI 1640
(Gibco, Grand Island, NY, U.S.A.) medium supplemented
with 10% fetal bovine serum (FBS, Dalian Biological Reagent
Factory, Dalian, China), 2 mM L-glutamine (Gibco), 100
U/mL penicillin, and 100  g/mL streptomycin, and main-
tained at 37℃ with 5% CO2 in a humidified atmosphere.
The cells at exponential phase of growth were used in these
experiments.
Nuclear morphology observed by Hoechst 33258 staining
Apoptotic nuclear morphology was assessed using Hoechst
33258 (Sigma) as described previously (24). Cells were fixed
with 3.7% paraformaldelyde for 30 min at room temperature,
then washed and stained with Hoechst 33258 167  M at
37℃for 30 min. The cells were then washed and resuspend-
ed in PBS for morphological observation using a fluorescence
microscope (Olympus, Tokyo, Japan).
Detection of DNA fragmentation
A375-S2 cells were incubated with 1 nM IL-1 for 0, 24,
48 and 72 hr. Both adherent and non-adherent cells (1×106
cells) were collected by centrifugation at 1,000×g for 5 min.
The cell pellets was suspended in cell lysis buffer [Tris-HCl
10 mM (pH 7.4), edetic acid 10 mM (pH 8.0), Triton-X100
(0.5%)] and kept at 4℃for 10 min. The lysate was centrifuged
at 25,000×g for 20 min. The supernatant was incubated
with RNase 40  g/L at 37℃ for 1 hr, and then incubated
with proteinase K 40  g/L at 37℃for 1 hr. The supernatant
was mixed with NaCl 0.5 M and 50 % 2-propanol at -20℃
overnight, and then centrifuged at 25,000×g for 15 min.
After drying, DNA was dissolved in TE buffer [Tris-HCl 10
mM (pH 7.4), edetic acid 1 mM (pH 8.0)] and separated by
2% agarose gel electrophoresis at 100 V for 1 hr.
Caspase activity assay
A375-S2 cells were treated with 1 nM IL-1 for 0, 12, 24,
48 and 72 hr. After washing in phosphate buffered saline, cells
were collected and lysed in 50  L of the cell lysis buffer in-
cluded in caspase-1, -3 and -8 apoptosis detection kit (Santa
Cruz Biotechnology). The enzymatic activities of caspase-1,
-3 and -8 activity were measured with caspase-1 substrate
(YVAD-AFC), capase-3 substrate (DEVD-AFC) and caspase-
8 substrate (IETD-AFC), respectively, according to the manu-
facturer’s instruction. The activity of capase-9 was measured
by caspase-9 colorimetric activity assay kit (Santa Cruz Biotech-
nology).
Quantitation of IL-1
After cell lysis and centrifugation at 12,000×g in 1.5 mL
Eppendorf tube, secreted IL-1 and pro-IL-1 were quanti-
tated by human cytokine specific radioimmunoassay (RIA).
Methods for RIA for human cytokines were followed as pre-
viously reported (25, 26). Exogenous IL-1 was substracted
from quantity of the measured IL-1 (pro- IL-1 plus IL-1 )
amount.
Western blot analysis 
A375-S2 cells were treated with 1 nM IL-1 for 0, 12,
24, 48 and 72 hr. Both adherent and floating cells were col-
lected. Then Western blot analysis was carried out with some
modification. Briefly, the cell pellets were resuspended in lysis
buffer, including HEPES (50 mM pH 7.4), Triton-X100 1%,
sodium orthovanadate (2 mM), sodium fluoride (100 mM),
edetic acid (1 mM), PMSF 1 mM (Sigma), aprotinin 10  g/
mL (Sigma), leupeptin 10  g/mL (Sigma), and lysed on ice for
60 min. After centrifugation of the cell suspension at 13,000
×g for 15 min, the protein content of supernatant was deter-
mined by Bio-Rad protein assay reagent (Bio-Rad, Hercules,
CA, U.S.A.). Equivalent amounts of protein lysates were mixed
in 2×loading buffer [50 mM Tris-HCl (pH 6.8), 2% SDS,
10% 2-mercaptoethanol, 10% glycerol, and 0.002% bromo-
phenol blue], heated at 100℃ for 5 min, then analyzed by
electrophoresis in 12% SDS polyacrylamide gel electrophoresisand blotted onto nitrocellulose membrane (Amersham Bio-
sciences, Piscataway, NJ, U.S.A.). Pro-IL-1 was detected
using polyclonal antiserum pro-IL-1 PARP, ICAD, Bcl-2,
Bcl-xL, Bax and AIF were detected using polyclonal antibodies
against them, followed by addition of secondary antibody con-
jugated with horseradish peroxidase (HRP) and 3,3-diamino-
benzidine tetrahydrochloride (DAB) as HRP substrate.
Statistical analysis
All data represent at least three independent experiments
and are expressed as the mean±S.D. unless otherwise indi-
cated. Statistical comparisons were made by Students’s t-test.
P-values of less than 0.05 were considered significant.
RESULTS
A375-S2 cells represent high sensitivity to IL-1
To examine the sensitivity of A375-S2 cells to human proin-
flammatory cytokines, we measured the anti-proliferative
effects of four cytokines, IL-1 , IL-1 , TNF- and IL-6, which
have cytocidal effects on A375-S2 cells. After incubation with
10-14 Mto 10-6 M cytokines for 72 hr, IL-1 showed the strongest
cytocidal effect among these cytokines at the same concentra-
tion (Fig. 1).
IL-1 -induced apoptotic cell death in A375-S2 cells
To determine the features of A375-S2 cell death induced
by IL-1 , apoptosis assessment assay including morpholog-
ical analysis and DNA fragmentation analysis were performed.
The nuclear morphologic changes were analyzed by Hoechst
33258 staining. In the control group, nuclei of A375-S2 cells
were round in shape and stained homogeneously (Fig. 2A).
After treatment with 1 nM IL-1 for 72 hr, apoptotic cells
had condensed and fragmented nuclei (Fig. 2B). Treatment
with 1 nM IL-1 for 72 hr resulted in typical DNA fragmen-
tation in agarose electrophoresis, which is a hallmark of apop-
tosis (Fig. 2C). These results suggested that IL-1 induced
A375-S2 cell death through apoptotic pathways.
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Fig. 1. Inhibitory effects of four cytokines on A375-S2 cells. A375-
S2 cells were incubated with IL-1 , IL-1 , TNF and IL-6 at vari-
ous doses for 72 hr. The data are presented as mean shown only
a part here of the results for three independent experiments.
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IL-1 alpha
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TNF alpha
IL-6
Fig. 2. IL-1 -induced apoptosis in A375-S2 cells. Morphologic
changes of A375-S2 cell nuclei were observed by fluorescence
microscopy. (A) medium control. (B) After treatment with 1 nM IL-
1 for 72 hr, the cells were stained with Hoechst 33258 using ×400
manification. Arrows indicate condensed and fragmented nuclei.
(C) Internucleosomal DNA fragmentation induced in A375-S2 cells
by IL-1 . The cells were treated with 1 nM IL-1 for 0, 24, 48 and
72 hr (lane 2, 3, 4 and 5; M: molecular weight marker).
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Caspase activity in A375-S2 cells was increased after
treatment with IL-1
To investigate the signal transduction pathways underlying
IL-1 -induced apoptosis in A375-S2 cells, assessment of cas-
pase-1, -3, -8 and -9 activities was performed. After treatment
with 1 nM IL-1 for 24 hr, activity of caspase-1 and upstream
caspase-8 reached a peak, 1.5 times (p<0.01) and 3 times (p<
0.01) higher than those of control group, respectively. Simul-
taneously, activity of caspase-9 was also increased to 3.7 times
(p<0.01) of control. Then downstream caspase-3 activation
was augmented to nearly four-fold increase (p<0.01) com-
pared to the control group at 48 hr (Fig. 3). 
Effects of IL-1 on PARP and ICAD expression in A375-
S2 cells
The two classical caspase substrate, PARP (poly ADP-ribose
polymerase) (27) and ICAD (inhibitor of caspase-activated
DNase) (28) were applied to investigate the role of down-
stream capases. As shown in Fig. 4, after incubation with 1
nM IL-1 for 12 hr, PARP protein was cleaved to 85 kDa
fragment and ICAD protein expression also decreased during
the apoptotic process. These results indicated that caspase-3’s
activation and cleavage of its substrates, PARP and ICAD,
were involved in IL-1 -induced apoptosis.
IL-1 induced endogenous IL-1 production by A375-S2
cells
The precursor of IL-1 (pro-IL-1 ) has been identified as
substrate for caspase-1 (IL-1 converting enzyme, ICE), and
pro-IL-1 (33 kDa) is inactive until its cleavage by caspase-1
into bioactive IL-1 (17.5 kDa) (29). To investigate whether
caspase-1
caspase-3
caspase-8
caspase-9
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Fig. 3. Effects of IL-1 on the activation of caspase-1, -3, -8 and
-9 in A375-S2 cells. The cells were treated with 1 nM IL-1 for 0,
12, 24, 48 and 72 hr. The data are presented as mean±S.D. of
the results for three independent experiments.
Fig. 4. Expression of PARP and ICAD in IL-1 -treated A375-S2
cells. The cells were treated with 1 nM IL-1 for 0, 12, 24, 48 and
72 hr. Cell lysates were separated by 12% SDS-PAGE electrophore-
sis, and PARP and ICAD proteins were detected by Western blot
analysis.
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Fig. 5. IL-1 -induced production of IL-1 by A375-S2 cells. (A)
The cells were treated with 1 nM IL-1 for 0, 12, 24, 48 and 72 hr.
The cell lysates were separated by 12% SDS-PAGE electrophore-
sis, and pro-IL-1 protein bands was detected by Western blot
analysis. (B) A375-S2 cells (1.25, 0.63, 0.32, 0.16, 0.08×10
6 cells/
mL) were treated with 0.005, 0.05, 0.5, 5 nM IL-1 for 24 hr. 
Fig. 6. IL-1 -induced mitochrondria-dependent apoptotic cell
death. A375-S2 cells were treated with 1 nM IL-1 for 0, 12, 24,
48 and 72 hr. The cell lysates were separated by 12% SDS-PAGE
electrophoresis, and the proteins were detected by Western blot
analysis.
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-actin Btreatment of exogenous IL-1 can increase the expression of
endogenous IL-1 , production of IL-1 was quantitated by
radioimmunoassay. In Western blot analysis, pro-IL-1 pro-
tein expression was not observed without administration of
exogenous IL-1 , and then was increased by treatment with
1 nM IL-1 especially at 24 hr (Fig. 5A). As shown in Fig. 5B,
after treatment with various doses of IL-1 for 24 hr, produc-
tion of IL-1 and pro-IL-1 were increased in a dose depen-
dent manner, although there was minor differences in sever-
al cell densities. These results indicated that exogenous IL-
1 induced-endogenous pro-IL-1 production and increased
caspase-1 activity had strong relationship to pro-IL-1 ’s cleav-
age to IL-1 and its secretion.
IL-1 induced mitochondrial pathway dependent apoptosis
in A375-S2 cells
In mitochondria, Bcl-2 family proteins play an important
role in the regulation of apoptosis. Some of them including
Bcl-2 and Bcl-xL suppress apoptosis, while others such as
Bax and Bid promote apoptosis (21, 30). Furthermore, AIF
is required for mitochondrial pathway dependent apoptosis
(31). In view of the roles of Bcl-2 family proteins and AIF
in the apoptotic pathway, Western blot analysis was carried
out to examine the expression ratio of Bcl-2, Bcl-xL, Bax and
AIF during the apoptosis. As shown in Fig. 6A, though Bax
expression level slightly increased, expression of Bcl-2 and
Bcl-xL were significantly reduced after exposure to 1 nM IL-
1 . The ratio of Bax/Bcl-2 and Bax/Bcl-xL expression increased
in a time dependent manner. As expected, AIF expression
level increased during IL-1 -induced apoptosis in A375-S2
cells (Fig. 6B). In view of these data, mitochondrial pathway
was supposed to participate in IL-1 -induced A375-S2 cell
apoptosis. 
DISCUSSION
Antiproliferative effect of IL-1 in human melanoma cell
A375 has been reported to be involved in some signaling
pathways (10-14), which had not been proved to be related
with apoptosis. In this study, we have obtained evidences
supporting that IL-1 could induce A375-S2 cell apoptosis
through caspase and mitochondrial pathways. Based on the
morphologic changes, DNA fragmentation, we concluded
that IL-1 induced A375-S2 cell death involved in a machin-
ery of apoptosis. Up-regulation of caspase-1, upstream cas-
pase-8, -9 and downstream caspase-3 activities confirmed
the participation of caspases in A375-S2 cell apoptosis. More-
over, caspase-8 might locate at downstream of IL-1 receptor
and play their roles in the apoptosis.
PARP and ICAD are downstream caspase-3 substrates that
control nuclear apoptosis. PARP is a 116 kDa nuclear enzyme
which detects and binds to DNA strand breaks and function
in transcription and DNA repair (27). CAD activation is
attributed to the cleavage of ICAD, which is cleaved by cas-
pase-3 or caspase-7 (32), resulting in DNA fragmentation.
In our study, caspase activity assay and Western blot analysis
showed that downstream caspase-3 was evidently activated
during A375-S2 cell apoptosis, and the endogenously exist-
ing PARP and ICAD in A375-S2 cells were down-regulat-
ed, leading to typical apoptotic chromatin condensation as
shown in Hoechst 33258 staining, and the consequent appear-
ance of DNA ladder in electrophoresis. Therefore, IL-1 trig-
gered the activation of caspase-3 which was responsible for
degradation of PARP and ICAD.
Caspase-1, which is also known as IL-1 -converting enzyme
(ICE), is a specific intracellular cysteine protease that cleaves
the precursor of IL-1 (pro-IL-1 ) into bioactive cytokine
(29). Our study demonstrated that both pro-IL-1 expres-
sion and endogenous IL-1 production in A375-S2 cells in-
creased after treatment with IL-1 . This augmentation ex-
hibited minor differences in various cell densities, that is,
when cell numbers increased, production of cytokine might
not necessarily increase. It was speculated that maybe when
the cell numbers increased excessively, some signaling trans-
duction pathways of cytokine production would be inhibited
or altered by cell excessive coalescence, the detailed machin-
ery in this process remains to be confirmed. After treatment
with IL-1 for 24 hr, pro-IL-1 expression reached a peak,
and simultaneously, caspase-1 was activated as described above,
indicating that induced pro-IL-1 was cleaved by caspase-1
(ICE) into IL-1 . Thus, IL-1 -induced apoptosis in A375-
S2 cells is not only a direct effect of caspase-1 as a member
of caspase cascade, but also is mediated indirectly through
pro-IL-1 synthesis and its cleavage by caspase-1.
A375-S2 cells express both the proapoptotic Bax and the
antiapoptotic Bcl-2 and Bcl-xL. Bcl-2 and Bcl-xL proteins are
known to act as antiapoptotic components that prevent Bax
from exerting its proapoptotic effect (21, 22). In our study,
A375-S2 cell apoptosis was associated with both decreased
Bcl-2 and Bcl-xL expression and slightly increased Bax expres-
sion, resulting in a sustained increase in the Bax/Bcl-2 and
Bax/Bcl-xL ratios and release of cytochrome c, which might
play a critical role in regulation of IL-1 -induced apoptosis.
Postmitochondrial caspase-9 activation is dependent on the
release of cytochrome c and formation of cytochrome c/Apaf-
1 (apoptotic protease-activating factor-1)/caspase-9 ‘apopto-
some’, and then downstream caspase-3 and AIF are activat-
ed (23). Therefore, AIF was thought to be essential for the
mitochondrial pathway dependent apoptosis. In the present
study, AIF activation was supposed to contribute to apopto-
sis in response to IL-1 treatment.
In conclusion, IL-1 induced A375-S2 cell apoptosis through
decreased expression of PARP and ICAD in response to the
activation of caspase cascade at earlier stage and induction of
endogenous IL-1 . Simultaneously, IL-1 -induced apoptosis
was mediated by mitochondria, through up-regulation of Bax
IL-1 and Human Melanoma A375-S2 Cell Apoptosis 559and down-regulation of Bcl-2, Bcl-xL to initiate caspase-9
activity, leading to the activation of caspase-3 and release of
AIF in this apoptotic process.
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